Thomas J. Smach
Known title: DirectorCIK: 0001194106
Thomas J. Smach's purchase track record
How the stock did after each of Thomas J. Smach's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
6
of 7 since February 17, 2022
Stock higher 6 months later
17%
3 months: 33%
Median 6-month return
-5.0%
3 months: -20.2%
Beat the S&P 500
33%
median -6.9% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/10/2026 | CROX | $513K | pending | pending | — |
| 7/28/2023 | CROX | $1.21M | -20.5% | -4.8% | +6.7% |
| 6/16/2023 | CROX | $222K | -20.0% | -2.6% | +7.0% |
| 3/13/2023 | CROX | $339K | +3.9% | -16.7% | +16.4% |
| 5/25/2022 | CROX | $250K | +51.1% | +90.4% | +1.2% |
| 3/3/2022 | CROX | $390K | -20.4% | -5.2% | -9.1% |
| 2/17/2022 | CROX | $1.07M | -33.9% | -6.3% | -2.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CROX | ▲ Buy | Open Market | 680 | $76K | 9/15/2026 | View on chart |
| CROX | ▲ Buy | Open Market | 1,000 | $109K | 9/10/2026 | View on chart |
| CROX | ▲ Buy | Open Market | 3,000 | $328K | 9/10/2026 | View on chart |
| CROX | ▲ Buy | Grant | 2,817 | $0 | 6/9/2026 | View on chart |
| CROX | ▲ Buy | Grant | 1,291 | $0 | 6/9/2026 | View on chart |
| CROX | ▼ Sell | Open Market | 4,963 | $496K | 2/20/2026 | View on chart |
| CROX | ▼ Sell | Open Market | 5,000 | $492K | 2/13/2026 | View on chart |
| CROX | ▲ Buy | Grant | 3,423 | $0 | 6/10/2025 | View on chart |
| CROX | ▲ Buy | Grant | 1,569 | $0 | 6/10/2025 | View on chart |
| CROX | ▼ Sell | Open Market | 9,139 | $1.0M | 5/9/2025 | View on chart |
| CROX | ▲ Buy | Grant | 1,815 | $0 | 6/4/2024 | View on chart |
| CROX | ▲ Buy | Grant | 1,311 | $0 | 6/4/2024 | View on chart |
| CROX | ▼ Sell | Open Market | 10,174 | $1.4M | 5/10/2024 | View on chart |
| CROX | ▲ Buy | Open Market | 7,500 | $790K | 8/2/2023 | View on chart |
| CROX | ▲ Buy | Open Market | 2,500 | $269K | 8/1/2023 | View on chart |
| CROX | ▲ Buy | Open Market | 478 | $50K | 7/28/2023 | View on chart |
| CROX | ▲ Buy | Open Market | 957 | $100K | 7/28/2023 | View on chart |
| CROX | ▲ Buy | Grant | 1,840 | $0 | 6/20/2023 | View on chart |
| CROX | ▲ Buy | Grant | 2,453 | $0 | 6/20/2023 | View on chart |
| CROX | ▲ Buy | Open Market | 2,000 | $222K | 6/16/2023 | View on chart |
| CROX | ▲ Buy | Open Market | 3,000 | $339K | 3/13/2023 | View on chart |
| CROX | ▲ Buy | Grant | 4,892 | $0 | 6/14/2022 | View on chart |
| CROX | ▲ Buy | Grant | 3,522 | $0 | 6/14/2022 | View on chart |
| CROX | ▲ Buy | Open Market | 5,000 | $250K | 5/25/2022 | View on chart |
| CROX | ▲ Buy | Open Market | 5,000 | $390K | 3/3/2022 | View on chart |
| CROX | ▲ Buy | Open Market | 6,897 | $596K | 2/17/2022 | View on chart |
| CROX | ▲ Buy | Open Market | 5,459 | $471K | 2/17/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Crocs (CROX) Announces Q3 2026 Earnings Call, Cites Growth
The company scheduled a conference call to discuss its third‑quarter 2026 earnings. Management highlighted accelerating international sales and expects continued growth in North America. A new partnership with BARK expands the brand into pet‑focused products, starting with a customizable dog bed. Recent commentary notes that Crocs' exposure to oil prices has diminished, improving cost stability.
Crocs (CROX) Announces Q3 2026 Earnings Call, Cites Growth. The company scheduled a conference call to discuss its third‑quarter 2026 earnings. Management highlighted accelerating international sales and expects continued growth in North America. A new partnership with BARK expands the brand into pet‑focused products, starting with a customizable dog bed. Recent commentary notes that Crocs' exposure to oil prices has diminished, improving cost stability.